Anthony Moorman

@avmoorman.bsky.social

Translational researcher based at Newcastle University specialising in acute lymphoblastic leukaemia

π‘―π’Šπ’ˆπ’‰π’π’Šπ’ˆπ’‰π’•π’Šπ’π’ˆ 𝑩-𝒄𝒆𝒍𝒍 𝑨𝒄𝒖𝒕𝒆 π‘³π’šπ’Žπ’‘π’‰π’π’ƒπ’π’‚π’”π’•π’Šπ’„ π‘³π’†π’–π’Œπ’‚π’†π’Žπ’Šπ’‚ (𝑩-𝑨𝑳𝑳) π’“π’†π’”π’†π’‚π’“π’„π’‰πŸ§¬ Our group lead @avmoorman.bsky.social presented on risk stratification in B-ALL at the International ALL Assembly, sponsored by @amgen.bsky.social. Great opportunity to share our work with the international research community.

The talk focused on risk stratification in 𝑩-𝒄𝒆𝒍𝒍 𝑨𝒄𝒖𝒕𝒆 π‘³π’šπ’Žπ’‘π’‰π’π’ƒπ’π’‚π’”π’•π’Šπ’„ π‘³π’†π’–π’Œπ’‚π’†π’Žπ’Šπ’‚ (𝑩-𝑨𝑳𝑳), emphasizing the role of cytogenetic approaches in identifying patient risk profiles and guiding treatment strategiesπŸ”¬πŸ“Š.The talk focused on risk stratification in 𝑩-𝒄𝒆𝒍𝒍 𝑨𝒄𝒖𝒕𝒆 π‘³π’šπ’Žπ’‘π’‰π’π’ƒπ’π’‚π’”π’•π’Šπ’„ π‘³π’†π’–π’Œπ’‚π’†π’Žπ’Šπ’‚ (𝑩-𝑨𝑳𝑳), emphasizing the role of cytogenetic approaches in identifying patient risk profiles and guiding treatment strategiesπŸ”¬πŸ“Š.

Hi everyone πŸ‘‹ Bluesky is growing so rapidly – so we want to share some key information about cancer, for anyone here who might need it. Nearly 1 in 2 people in the UK will get cancer – so if this thread might be of use to anyone you know, please pass it on to them. 1/3

Glad to share the work of the fantastic Cancer Biomarkers Laboratory of St Jude showing the power and utility of cell free genomic analysis to detect diverse genomic variants in leukemia and many solid tumors. Exciting potential for mutation-specific monitoring. www.nature.com/articles/s41...

Genomic profiling of circulating tumor DNA for childhood cancers - Leukemia

Leukemia - Genomic profiling of circulating tumor DNA for childhood cancers

nature.com